Research & IP Evaluation Expertise

Our life science intellectual property practice provides analysis, assessment and strategic advice on life science IP. The practice is focused on both helping clients extract maximum value from their IP portfolios and supporting companies and investors conducting IP due diligence.

Cytopharma has considerable experience in working with academic research institutions and has worked with many universities, public- and third-sector research institutes, and research charities worldwide. We also undertake intellectual property due diligence on behalf of investor or acquirers, to support a transaction or asset valuation.

Typical work conducted:

The service is designed to sit alongside what is offered by established patent firms. We do not file and maintain patents but provide high-level strategic advice. For example, patent applications and procedures can take on a life of their own, with organizational inertia masking the need for a decision. We can provide a realistic, commercially relevant reality check, helping clients rationalize and prioritize IP assets, and plan their commercialization.

Our technical areas of expertise span the following aspects, across therapeutic areas: